A new paper in the Journal of Clinical and Translational Science finds that travel distance to National Cancer Institute (NCI)-funded sites remains a key barrier for patients wanting to participate in clinical trials or research at these locations.

Dr. Anthony Letai has been named as the National Cancer Institute (NCI)’s new director. This role is critical to ensuring ongoing innovation in oncology. The following is a statement from the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) to this announcement: “For the

Today, the U.S. House Committee on Ways and Means is expected to mark up the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act (H.R. 842).

As the September 30th government funding deadline nears, more than 700 cancer patients, survivors and advocates from every corner of the United States, including Washington, D.C., Guam, and Puerto Rico, are heading to Capitol Hill to make their voices heard. They will ask lawmakers to prioritize cancer research and prevention programs, along with other proven cancer-fighting policies, highlighting the real-life impact these investments have on patients, families and communities nationwide.